Mark Ogunsusi is an associate in the Drug Pricing and 340B Program practice group of Powers Pyles Sutter & Verville PC. He focuses his practice primarily on regulatory matters involving pharmaceutical pricing and the 340B drug pricing program. In addition to holding his legal degree, he is a Doctor of Pharmacy. He regularly advises an array of health care entities on the nuances of the 340B program, the Medicaid drug rebate program, federal pharmacy law, food and drug law, and state pharmacy law. He has significant experience in all aspects of the 340B program, including covered entity registrations, contract pharmacy arrangements, patient eligibility determinations, duplicate discount issues, drug inventory management, eligibility requirements, third-party vendor arrangements, auditable records requirements, and other 340B program compliance matters. He has more than 10 years of experience as a pharmacist that informs his health law practice. His other relevant prior experience includes serving as the CEO of PrystM LLC, a health care and technology consulting firm. Prior to attending law school, he worked in several different health care settings, including years of service at one of the nation's largest safety-net hospitals. He is a fervent advocate for promoting access to pharmaceutical care and supporting the nation's safety-net providers. He earned his J.D. from Georgetown University Law Center and graduated, cum laude, with a Doctor of Pharmacy from Mercer University College of Pharmacy.